Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ClearPoint Neuro, Inc. (CLPT : NSDQ)
 
 • Company Description   
ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

Number of Employees: 115

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.40 Daily Weekly Monthly
20 Day Moving Average: 501,326 shares
Shares Outstanding: 27.99 (millions)
Market Capitalization: $319.08 (millions)
Beta: 0.92
52 Week High: $19.22
52 Week Low: $6.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.21% -5.68%
12 Week -6.86% -21.40%
Year To Date -25.88% -30.35%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
120 S. SIERRA AVE. SUITE 100
-
SOLANA BEACH,CA 92075
USA		 ph: 888-287-9109
fax: 949-900-6834		 ir@clearpointneuro.com http://www.clearpointneuro.com
 
 • General Corporate Information   
Officers
Joseph M. Burnett - President; Chief Executive Officer; and Director
R. John Fletcher - Chairman and Director
Danilo D'Alessandro - Chief Financial Officer
Lynnette C. Fallon - Director
Pascal E.R. Girin - Director

Peer Information
ClearPoint Neuro, Inc. (ABMD)
ClearPoint Neuro, Inc. (DMDS)
ClearPoint Neuro, Inc. (CPWY.)
ClearPoint Neuro, Inc. (EQUR)
ClearPoint Neuro, Inc. (ECIA)
ClearPoint Neuro, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 18507C103
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 27.99
Most Recent Split Date: 7.00 (0.03:1)
Beta: 0.92
Market Capitalization: $319.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.76 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 15.96
Price/Cash Flow: -
Price / Sales: 9.90
EPS Growth
vs. Year Ago Period: -37.50%
vs. Previous Quarter: -10.00%
Sales Growth
vs. Year Ago Period: 11.07%
vs. Previous Quarter: 9.19%
ROE
06/30/25 - -
03/31/25 - -78.09
12/31/24 - -62.47
ROA
06/30/25 - -
03/31/25 - -51.33
12/31/24 - -40.76
Current Ratio
06/30/25 - -
03/31/25 - 3.53
12/31/24 - 3.22
Quick Ratio
06/30/25 - -
03/31/25 - 2.57
12/31/24 - 2.56
Operating Margin
06/30/25 - -
03/31/25 - -64.51
12/31/24 - -60.26
Net Margin
06/30/25 - -
03/31/25 - -64.51
12/31/24 - -60.26
Pre-Tax Margin
06/30/25 - -
03/31/25 - -64.50
12/31/24 - -60.26
Book Value
06/30/25 - -
03/31/25 - 0.71
12/31/24 - 0.92
Inventory Turnover
06/30/25 - -
03/31/25 - 1.75
12/31/24 - 1.64
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©